Different disease modifying therapies can increase or decrease Covid-19 severity in Multiple Sclerosis

被引：0

作者：

Sormani, Maria Pia ^{[1
]}

De Rossi, Nicola ^{[2
]}

Schiavetti, Irene ^{[1
]}

Carmisciano, Luca ^{[1
]}

Cordioli, Cinzia ^{[2
]}

Moiola, Lucia ^{[3
]}

Radaelli, Marta ^{[4
,5
]}

Immovilli, Paolo ^{[6
]}

Capobianco, Marco ^{[7
]}

Trojano, Maria ^{[8
]}

Zaratin, Paola ^{[9
]}

Tedeschi, Gioacchino ^{[10
]}

Comi, Giancarlo ^{[11
]}

Battaglia, Mario Alberto ^{[9
]}

Patti, Francesco ^{[12
]}

Salvetti, Marco ^{[13
]}

机构：

[1] Univ Genoa, Dept Hlth Sci, Genoa, Italy

[2] ASST Spedali Civili Brescia, Ctr Sclerosi Multipla, Brescia, Italy

[3] IRCCS Osped San Raffaele, Dept Neurol, Multiple Sclerosis Ctr, Milan, Italy

[4] ASST Papa Giovanni XXIII, Dept Neurol, Bergamo, Italy

[5] ASST Papa Giovanni XXIII, Multiple Sclerosis Ctr, Bergamo, Italy

[6] Osped Guglielmo Saliceto, Multiple Sclerosis Ctr, Piacenza, Italy

[7] Univ Hosp San Luigi, Dept Neurol, Reg Referral Multiple Sclerosis, Orbassano, Italy

[8] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy

[9] Italian Multiple Sclerosis Fdn, Res Dept, Genoa, Italy

[10] Univ Campania, Dept Adv Med & Surg Sci, Naples, Italy

[11] IRCCS Osped San Raffaele, Inst Expt Neurol, Milan, Italy

[12] Univ Catania, Policlin Catania, Ctr Sclerosi Multipla, Catania, Italy

[13] Sapienza Univ Rome, Dept Neurosci Mental Hlth & Sensory Organs, Rome, Italy

来源：

NEUROLOGY | 2021年 / 96卷 / 15期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

2021

引用

页数：5

共 50 条

[41] Insight in booster COVID-19 vaccine and disease modifying therapy in multiple sclerosis
Beard, Katherine
Sriwastava, Shitiz
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 430
[42] Disease modifying therapies in multiple sclerosis
Sharrack, B.
Jenkins, T.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (05) : 532 - 534
[43] Disease modifying therapies in multiple sclerosis
Khatri, BO
McQuillen, MP
NEUROLOGY, 2002, 59 (03) : 471 - 472
[44] Response to COVID-19 mRNA Vaccination in Patients with Multiple Sclerosis on anti-CD20 Disease Modifying Therapies
Wolf, Andrew
Pratt, Robert W.
Crooks, Kristy
Borko, Tyler
Gonzalez, Jose Parra
Vollmer, Timothy
Frazer-Abel, Ashley
ANNALS OF NEUROLOGY, 2021, 90 : S179 - S180
[45] Association between disease-modifying therapies and adverse clinical outcomes in multiple sclerosis patients with COVID-19 infection
Maghbooli, Zhila
Hosseinpour, Hesham
Fattahi, Mohammad Reza
Varzandi, Tarlan
Hamtaeigashi, Sara
Mohammad-nabi, Sara
Aghababaei, Yasaman
Sahraian, Mohammad Ali
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 67
[46] Response of COVID-19 vaccination in multiple sclerosis patients following disease-modifying therapies: A meta-analysis
Wu, Xi
Wang, Lu
Shen, Lu
Tang, Kefu
EBIOMEDICINE, 2022, 81
[47] Association between disease-modifying therapies and adverse clinical outcomes in multiple sclerosis patients with COVID-19 infection
Maghbooli, Z.
Aghababaei, Y.
Hosseinpour, H.
Fatahi, M.
Varzandi, T.
Hamtaee, S.
Mohammad-Nabi, S.
Eskandarieh, S.
Aghighi, M.
Moghadasi, A. Naser
Sahraian, M.
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 76 - 77
[48] The role of disease modifying therapies in rate and severity of COVID-19 infection in a cohort of MS and NMOSD
Nabavi, M.
Samimi, M.
Dastoorpur, M.
Yazdanbakhsh, S.
Najafian, A.
Faghani, L.
Zarvani, A.
MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 733 - 734
[49] Association between multiple sclerosis disease severity and adherence to disease-modifying therapies
Burkhard, Adam
Toliver, Joshua
Rascati, Karen
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2021, 27 (07): : 915 - 923
[50] Breakthrough COVID-19 in people with multiple sclerosis on disease modifying treatments: Is it still a severe disease?
Immovilli, Paolo
Schiavetti, Irene
Franceschini, Alessandro
De Mitri, Paola
Gelati, Lorenza
Rota, Eugenia
Guidetti, Donata
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 85

← 1 2 3 4 5 →